The Effects of Expectation and Knowledge on Rizatriptan [Maxalt] and Placebo Treatment of Acute Migraine Headache.

Trial Profile

The Effects of Expectation and Knowledge on Rizatriptan [Maxalt] and Placebo Treatment of Acute Migraine Headache.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Jul 2014

At a glance

  • Drugs Rizatriptan (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Sep 2012 Planned end date changed from 1 Sep 2010 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 05 Sep 2012 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 31 Jan 2012 Actual patient number (76) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top